Kidney Cancer News and Research

RSS
Kidney cancer is usually defined is a cancer that originates in the kidney. The two most common types of kidney cancer, reflecting their location within the kidney, are renal cell carcinoma (RCC) and urothelial cell carcinoma (UCC) of the renal pelvis.
Extensive cancer research data to be presented at the 2021 ASCO Annual Meeting

Extensive cancer research data to be presented at the 2021 ASCO Annual Meeting

Combination approach can improve the success rate of cancer treatment

Combination approach can improve the success rate of cancer treatment

Advanced-stage kidney cancer more common in Hispanic and Native Americans in Arizona

Advanced-stage kidney cancer more common in Hispanic and Native Americans in Arizona

Study could pave way for new therapies for kidney disease

Study could pave way for new therapies for kidney disease

Race, neighborhood poverty, insurance associated with higher mortality in people under 40 with cancer

Race, neighborhood poverty, insurance associated with higher mortality in people under 40 with cancer

Researchers develop a new method for the detection and evolution of kidney cancer

Researchers develop a new method for the detection and evolution of kidney cancer

Baseline brain imaging should be considered in most metastatic kidney cancer patients, study suggests

Baseline brain imaging should be considered in most metastatic kidney cancer patients, study suggests

Battle brews over neutral zone where border-crossing parties rendezvous, risking detection and infection

Battle brews over neutral zone where border-crossing parties rendezvous, risking detection and infection

Study shows safety, efficacy of percutaneous thermal ablation for treating metastatic gynecologic cancers

Study shows safety, efficacy of percutaneous thermal ablation for treating metastatic gynecologic cancers

Researchers reveal a mechanistic link in kidney cancer between fat metabolism and obesity

Researchers reveal a mechanistic link in kidney cancer between fat metabolism and obesity

Studies reveal how kidney tumors' microenvironments change in response to immunotherapy

Studies reveal how kidney tumors' microenvironments change in response to immunotherapy

Targeted drug combined with immunotherapy prolongs survival in patients with advanced kidney cancer

Targeted drug combined with immunotherapy prolongs survival in patients with advanced kidney cancer

Study explores impact of surgical delay for renal cell carcinoma during COVID-19 pandemic

Study explores impact of surgical delay for renal cell carcinoma during COVID-19 pandemic

Researchers elucidate mechanism by which blood and lymph vessels remain separated

Researchers elucidate mechanism by which blood and lymph vessels remain separated

Potentially promising therapeutic combination for renal cell carcinoma uncovered

Potentially promising therapeutic combination for renal cell carcinoma uncovered

Study reveals the role of SETD2 protein in cancer cells, cell migration, and autophagy

Study reveals the role of SETD2 protein in cancer cells, cell migration, and autophagy

Study: Tumors with high TMB tend to respond better to immune checkpoint inhibitors

Study: Tumors with high TMB tend to respond better to immune checkpoint inhibitors

Study finds increasing incidence of cancer among adolescents and young adults

Study finds increasing incidence of cancer among adolescents and young adults

Combining cell engineering with machine learning to design living medicines for cancer

Combining cell engineering with machine learning to design living medicines for cancer

Antiangiogenic drugs increase the aggressiveness of some kidney tumors

Antiangiogenic drugs increase the aggressiveness of some kidney tumors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.